Irinotecan use during pregnancy

Obstetrics and Gynecology

Volumn 114, Issue 2 PART 2 SUPPL., 2009, Pages 451-452

  Taylor, Justin ^b   Amanze, Adanna ^b   Di Federico, Elaine ^b   Verschraegen, Claire ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; TRANSCRIPTION FACTOR CDX2;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; COLORECTAL CANCER; DRUG SAFETY; ECHOGRAPHY; FEMALE; FETUS ELECTROCARDIOGRAPHY; FETUS OUTCOME; HUMAN; LAPAROTOMY; METASTASIS; MULTIPLE CYCLE TREATMENT; NEWBORN; OVARY CARCINOMA; PATIENT MONITORING; PELVIS RADIOGRAPHY; POSTNATAL DEVELOPMENT; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; SECOND TRIMESTER PREGNANCY; TREATMENT DURATION;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; COLONIC NEOPLASMS; FEMALE; HUMANS; KRUKENBERG TUMOR; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRENATAL CARE;

EID: 68949103529     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181a1d478     Document Type: Article

References (7)

1. Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 2008;34:302-12.
2. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-91.
3. Baker PM, Oliva E. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol 2005;24:39-55.
4. Sayar H, Lhomme C, Verschraegen CF. Malignant adnexal masses in pregnancy. Obstet Gynecol Clin North Am 2005;32:569-93.
5. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan Study Group. N Engl J Med 2000;343:905-14.
6. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [published erratum appears in Lancet 2000;355:1372]. Lancet 2000;355:1041-7.
7. Haluska P, Rubin E, Verschraegen CF. Topoisomerase-I inhibitors in gynecologic tumors. Hematol Oncol Clin North Am 1999;13:43-61.